Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related P...(zona Heart Institute has been dedicated ...),Health

Date:9/28/2007

zona Heart Institute has been dedicated to the prevention, detection and treatment of cardiac and cardiovascular disorders. Its team of board-certified specialists uses the latest means to diagnose the threat of heart and vascular disease before it strikes. The Arizona Heart Institute performs nearly all diagnostic tests on site, providing patients with the convenience of a complete, same-day analysis on an outpatient basis. Patients requiring interventional procedures such as endoluminal grafting are treated and cared for by our same team of specialists at the Arizona Heart Hospital. For more information, visit the Arizona Heart Institute Website at http://www.azheart.com.

Learn More about Thoracic Aortic Aneurysms

Endovascular Treatment of a Descending Thoracic Aortic Aneurysm Dr. Edward B. Diethrich and Dr. Grayson Wheatley Apply New Technology to a Thoracic Aneurysm

Related Links and References

Abstract - Application of endograft to treat thoracic aortic pathologies:

A single center experience

International Society of Endovascular Specialists

International Congress XXI Endovascular Interventions

'/>"/>

SOURCE The Arizona Heart Institute Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
7. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
8. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting